| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.45 | 0.004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.47 | 0.004 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |